PetMed Express, Inc. Announces Appointment of Peter Batushansky to Board of Directors

Core Insights - PetMed Express, Inc. has appointed Peter Batushansky to its Board of Directors, effective April 09, 2025, marking the third independent director added since 2024 [1][2] - Dr. Gian Fulgoni, a longtime board member and former Chairman, will retire at the 2025 annual shareholders' meeting [1][2] - The company is undergoing a leadership transformation, with recent appointments including Leslie C. G. Campbell as Chairman and Sandra Campos as CEO [2][3] Company Strategy and Leadership - The addition of Mr. Batushansky is part of the company's strategy to enhance board composition and support its transformation plan aimed at driving shareholder value [2][3] - The board will consist of seven directors, six of whom are independent, with three new members added since 2024 [2] - Mr. Batushansky's experience in retail, pet, and healthcare sectors is expected to align with the company's ambitions to expand its business in the pet wellness ecosystem [3][4] Background of New Board Member - Mr. Batushansky has over 20 years of experience in various industries, including roles as CEO of Allivet and WebEyeCare [4][5] - Currently, he is a Partner at L2 Capital Partners, contributing to his extensive background in private equity [5][6] Company Overview - PetMed Express, founded in 1996, is a leader in the consumer pet healthcare sector, operating as a national online retailer [7] - The company offers a range of pet health products, including pharmaceuticals and supplements, through its websites [7]